Adstiladrin Disease Interactions
There is 1 disease interaction with Adstiladrin (nadofaragene firadenovec).
Nadofaragene firadenovac (applies to Adstiladrin) immunosuppression
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency
Nadofaragene firadenovac is a non-replication adenoviral vector-based gene therapy. Patients who are immunocompromised or immunodeficient may be at risk for disseminated adenovirus infection. Avoid exposure to this drug in those patients.
Switch to professional interaction data
Adstiladrin drug interactions
There are 310 drug interactions with Adstiladrin (nadofaragene firadenovec).
Report options
More about Adstiladrin (nadofaragene firadenovec)
- Adstiladrin consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Padcev
Padcev (enfortumab vedotin) is an antibody-drug conjugate that is given as an intravenous infusion ...
Platinol
Platinol is used for bladder cancer, blood cell transplantation, bone marrow transplantation, brain ...
Enfortumab vedotin
Enfortumab vedotin systemic is used for bladder cancer, urothelial carcinoma
Mitomycin
Mitomycin systemic is used for anal cancer, bladder cancer, pancreatic cancer, stomach cancer ...
Durvalumab
Durvalumab (Imfinzi) is an immunotherapy used to treat lung cancer (NSCLC, SCLC) and other cancers ...
Doxorubicin
Doxorubicin systemic is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
